1. Home
  2. GEL vs BEAM Comparison

GEL vs BEAM Comparison

Compare GEL & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEL
  • BEAM
  • Stock Information
  • Founded
  • GEL 1996
  • BEAM 2017
  • Country
  • GEL United States
  • BEAM United States
  • Employees
  • GEL N/A
  • BEAM N/A
  • Industry
  • GEL Oil Refining/Marketing
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GEL Energy
  • BEAM Health Care
  • Exchange
  • GEL Nasdaq
  • BEAM Nasdaq
  • Market Cap
  • GEL 2.1B
  • BEAM 1.7B
  • IPO Year
  • GEL 1996
  • BEAM 2020
  • Fundamental
  • Price
  • GEL $16.80
  • BEAM $25.10
  • Analyst Decision
  • GEL Buy
  • BEAM Strong Buy
  • Analyst Count
  • GEL 3
  • BEAM 10
  • Target Price
  • GEL $19.50
  • BEAM $49.78
  • AVG Volume (30 Days)
  • GEL 457.6K
  • BEAM 3.0M
  • Earning Date
  • GEL 10-30-2025
  • BEAM 11-04-2025
  • Dividend Yield
  • GEL 4.03%
  • BEAM N/A
  • EPS Growth
  • GEL N/A
  • BEAM N/A
  • EPS
  • GEL N/A
  • BEAM N/A
  • Revenue
  • GEL $2,877,249,000.00
  • BEAM $60,272,000.00
  • Revenue This Year
  • GEL N/A
  • BEAM N/A
  • Revenue Next Year
  • GEL $19.09
  • BEAM $18.20
  • P/E Ratio
  • GEL N/A
  • BEAM N/A
  • Revenue Growth
  • GEL 17.61
  • BEAM N/A
  • 52 Week Low
  • GEL $9.86
  • BEAM $13.53
  • 52 Week High
  • GEL $17.77
  • BEAM $35.25
  • Technical
  • Relative Strength Index (RSI)
  • GEL 52.44
  • BEAM 72.69
  • Support Level
  • GEL $15.86
  • BEAM $19.57
  • Resistance Level
  • GEL $16.65
  • BEAM $21.59
  • Average True Range (ATR)
  • GEL 0.44
  • BEAM 1.56
  • MACD
  • GEL -0.02
  • BEAM 0.65
  • Stochastic Oscillator
  • GEL 62.67
  • BEAM 99.73

About GEL Genesis Energy L.P. Common Units

Genesis Energy LP is a limited partnership company that focuses on the midstream segment of the crude oil and natural gas industry. It engages in providing services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are offshore pipeline transportation, sodium minerals, and sulfur services, onshore facilities and transportation, and marine transportation. It generates maximum revenue from the offshore pipeline transportation segment which conducts crude oil and natural gas pipeline transportation and handling operations in the Gulf of Mexico through its offshore pipeline transportation segment, which focuses on providing a suite of services to integrated and large independent energy companies.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: